Who manufactures Comirnaty LP.8.1 30 µg/dose inj. disp. i.m. vial?

BioNTech Manufacturing GmbH (BE)

What ATC class does Comirnaty LP.8.1 30 µg/dose inj. disp. i.m. vial belong to?

Comirnaty LP.8.1 30 µg/dose inj. disp. i.m. vial: ATC J07BN01 Covid-19, RNA-based Vaccine. ATC is the WHO Anatomical Therapeutic Chemical classification.

OTC

Comirnaty LP.8.1 30 µg/dose inj. disp. i.m. vial

Q: What pharmaceutical form is Comirnaty LP.8.1 30 µg/dose inj. disp. i.m. vial available in?

Comirnaty LP.8.1 30 µg/dose inj. disp. i.m. vial: Dispersion for injection (Intramuscular use)

Dispersion for injection

INN: 5'-capped mRNA encoding SARS-CoV-2, Variant LP.8.1., Spike Protein, pre-fusion stabilised (K981P and V982P)

Data updated: 2026-04-11

Tillgängligt i:

🇩🇪🇬🇧🇫🇷

Beredningsform

Dispersion for injection

Dosering

—

Administreringsväg

Intramuscular use

Förvaring

—

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.